Hyaluronic acid-bearing lipoplexes: Physico-chemical characterization and in vitro targeting of the CD44 receptor

Journal of Controlled Release

Volumn 162, Issue 3, 2012, Pages 545-552

  Dufaÿ Wojcicki, Amélie ^a,b   Hillaireau, Hervé ^a,b   Nascimento, Thais Leite ^a,b   Arpicco, Silvia ^c   Taverna, Myriam ^a,b   Ribes, Sandy ^a,d   Bourge, Mickaël ^e   Nicolas, Valérie ^a,f   Bochot, Amélie ^a,b   Vauthier, Christine ^a,b   Tsapis, Nicolas ^a,b   Fattal, Elias ^a,b  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b UNIV PARIS SUD   (France)

^c UNIVERSITY OF TURIN   (Italy)

^d EA4123   (France)

^e Pôle de Biologie Cellulaire   (France)

^f IPSIT   (France)

Author keywords

A549; CD44; Complement activation; Endocytosis; Hyaluronic acid; Lipoplexes

Indexed keywords

A549; CD44; ENDOCYTOSIS; HYALURONIC ACIDS; LIPOPLEXES;

CELL CULTURE; DEGRADATION; ELECTROPHORESIS; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; LIPIDS; LIPOSOMES; MOLECULAR BIOLOGY; MOLECULAR WEIGHT; ORGANIC ACIDS; ZETA POTENTIAL;

DNA;

CATION; GREEN FLUORESCENT PROTEIN; HERMES ANTIGEN; HYALURONIC ACID; LIPOPLEX; LIPOSOME; NUCLEASE;

ARTICLE; COMPLEMENT SYSTEM; DNA DETERMINATION; ELECTROPHORESIS; ENZYME DEGRADATION; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IMMUNOELECTROPHORESIS; IN VITRO STUDY; MOLECULAR WEIGHT; PHYSICAL CHEMISTRY; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; VALIDATION PROCESS; ZETA POTENTIAL;

ANTIGENS, CD44; CELL LINE, TUMOR; COMPLEMENT C3; DNA; ENDOCYTOSIS; GREEN FLUORESCENT PROTEINS; HUMANS; HYALURONIC ACID; LIPOSOMES; PHOSPHATIDYLETHANOLAMINES;

EID: 84865608171     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2012.07.015     Document Type: Article

References (36)

1. C. Tros de Ilarduya, Y. Sun, and N. Düzgüneş Gene delivery by lipoplexes and polyplexes Eur. J. Pharm. Sci. 40 2010 159 170
2. Y. Liu, D. Liggitt, W. Zhong, G. Tu, K. Gaensler, and R. Debs Cationic liposome-mediated intravenous gene delivery J. Biol. Chem. 270 1995 24864 24870
3. M.J. Stewart, G.E. Plautz, L. Del Buono, Z.Y. Yang, L. Xu, X. Gao, L. Huang, E.G. Nabel, and G.J. Nabel Gene transfer in vivo with DNA-liposome complexes: safety and acute toxicity in mice Hum. Gene Ther. 3 1992 267 275
4. N. Zhu, D. Liggitt, Y. Liu, and R. Debs Systemic gene expression after intravenous DNA delivery into adult mice Science 261 1993 209 211
5. Y. Yang, F.A. Nunes, K. Berencsi, E.E. Furth, E. Gonczol, and J.M. Wilson Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy Proc. Natl. Acad. Sci. U. S. A. 91 1994 4407 4411
6. M.R. Knowles, K.W. Hohneker, Z. Zhou, J.C. Olsen, T.L. Noah, P.C. Hu, M.W. Leigh, J.F. Engelhardt, L.J. Edwards, K.R. Jones, M. Grossman, J.M. Wilson, L.G. Johnson, and R.C. Boucher A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis N. Engl. J. Med. 333 1995 823 831
7. A.R. Thierry, Y. Lunardi-Iskandar, J.L. Bryant, P. Rabinovich, R.C. Gallo, and L.C. Mahan Systemic gene therapy: biodistribution and long-term expression of a transgene in mice Proc. Natl. Acad. Sci. U. S. A. 92 1995 9742 9746
8. R.I. Mahato, K. Kawabata, T. Nomura, Y. Takakura, and M. Hashida Physicochemical and pharmacokinetic characteristics of plasmid DNA/cationic liposome complexes J. Pharm. Sci. 84 1995 1267 1271
9. M.B. Bally, P. Harvie, F.M. Wong, S. Kong, E.K. Wasan, and D.L. Reimer Biological barriers to cellular delivery of lipid-based DNA carriers Adv. Drug Deliv. Rev. 38 1999 291 315
10. F. Shi, L. Wasungu, A. Nomden, M.C. Stuart, E. Polushkin, J.B. Engberts, and D. Hoekstra Interference of poly(ethylene glycol)-lipid analogues with cationic-lipid-mediated delivery of oligonucleotides; role of lipid exchangeability and non-lamellar transitions Biochem. J. 366 2002 333 341
11. S.C. Semple, T.O. Harasym, K.A. Clow, S.M. Ansell, S.K. Klimuk, and M.J. Hope Immunogenicity and rapid blood clearance of liposomes containing polyethylene glycol-lipid conjugates and nucleic Acid J. Pharmacol. Exp. Ther. 312 2005 1020 1026
12. P.W. Noble Hyaluronan and its catabolic products in tissue injury and repair Matrix Biol. 21 2002 25 29
13. R. Deed, P. Rooney, P. Kumar, J.D. Norton, J. Smith, A.J. Freemont, and S. Kumar Early-response gene signalling is induced by angiogenic oligosaccharides of hyaluronan in endothelial cells. Inhibition by non-angiogenic, high-molecular-weight hyaluronan Int. J. Cancer 71 1997 251 256
14. E.L. Pardue, S. Ibrahim, and A. Ramamurthi Role of hyaluronan in angiogenesis and its utility to angiogenic tissue engineering Organogenesis 4 2008 203 214
15. D. Peer, and R. Margalit Loading mitomycin C inside long circulating hyaluronan targeted nano-liposomes increases its antitumor activity in three mice tumor models Int. J. Cancer 108 2004 780 789
16. D. Peer, and R. Margalit Tumor-targeted hyaluronan nanoliposomes increase the antitumor activity of liposomal Doxorubicin in syngeneic and human xenograft mouse tumor models Neoplasia 6 2004 343 353
17. C. Surace, S. Arpicco, A. Dufay-Wojcicki, V. Marsaud, C. Bouclier, D. Clay, L. Cattel, J.M. Renoir, and E. Fattal Lipoplexes targeting the CD44 hyaluronic acid receptor for efficient transfection of breast cancer cells Mol. Pharm. 6 2009 1062 1073
18. M. Al-Hajj, M.S. Wicha, A. Benito-Hernandez, S.J. Morrison, and M.F. Clarke Prospective identification of tumorigenic breast cancer cells Proc. Natl. Acad. Sci. U. S. A. 100 2003 3983 3988
19. S. Arpicco, S. Canevari, M. Ceruti, E. Galmozzi, F. Rocco, and L. Cattel Synthesis, characterization and transfection activity of new saturated and unsaturated cationic lipids Il Farmaco 59 2004 869 878
20. J. Grimshaw, J. Trocha-Grimshaw, W. Fisher, A. Rice, S. Smith, P. Spedding, J. Duffy, and R. Mollan Quantitative analysis of hyaluronan in human synovial fluid using capillary electrophoresis Electrophoresis 17 1996 396 400
21. R. Diaz-Lopez, N. Tsapis, M. Santin, S. Bridal, V. Nicolas, D. Jaillard, D. Libong, P. Chaminade, V. Marsaud, C. Vauthier, and E. Fattal The performance of PEGylated nanocapsules of perfluorooctyl bromide as an ultrasound contrast agent Biomaterials 2010 1723 1731
22. M. Kazatchkine, G. Hauptmann, and U. Nydegger Techniques du complément 1986 INSERM Paris
23. S.J. Eastman, C. Siegel, J. Tousignant, A.E. Smith, S.H. Cheng, and R.K. Scheule Biophysical characterization of cationic lipid: DNA complexes Biochim. Biophys. Acta 1325 1997 41 62
24. O. Zelphati, L.S. Uyechi, L.G. Barron, and F.C. Szoka Jr. Effect of serum components on the physico-chemical properties of cationic lipid/oligonucleotide complexes and on their interactions with cells Biochim. Biophys. Acta 1390 1998 119 133
25. S. Mizrahy, S.R. Raz, M. Hasgaard, H. Liu, N. Soffer-Tsur, K. Cohen, R. Dvash, D. Landsman-Milo, M.G.E.G. Bremer, S.M. Moghimi, and D. Peer Hyaluronan-coated nanoparticles: the influence of the molecular weight on CD44-hyaluronan interactions and on the immune response J. Control. Release 156 2011 231 238
26. N.S. Chang, and R.J. Boackle Glycosaminoglycans enhance complement hemolytic efficiency: theoretical considerations for GAG-complement-saliva interactions Mol. Immunol. 23 1986 887 893
27. C. Plank, K. Mechtler, F.C. Szoka Jr.; and E. Wagner Activation of the complement system by synthetic DNA complexes: a potential barrier for intravenous gene delivery Hum. Gene Ther. 7 1996 1437 1446
28. S. Taetz, A. Bochot, C. Surace, S. Arpicco, J.M. Renoir, U.F. Schaefer, V. Marsaud, S. Kerdine-Roemer, C.M. Lehr, and E. Fattal Hyaluronic acid-modified DOTAP/DOPE liposomes for the targeted delivery of anti-telomerase siRNA to CD44-expressing lung cancer cells Oligonucleotides 19 2009 103 115
29. H.S.S. Qhattal, and X. Liu Characterization of CD44-mediated cancer cell uptake and intracellular distribution of hyaluronan-grafted liposomes Mol. Pharm. 8 2011 1233 1246
30. L.H. Wang, K.G. Rothberg, and R.G. Anderson Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation J. Cell Biol. 123 1993 1107 1117
31. J.E. Schnitzer, P. Oh, E. Pinney, and J. Allard Filipin-sensitive caveolae-mediated transport in endothelium: reduced transcytosis, scavenger endocytosis, and capillary permeability of select macromolecules J. Cell Biol. 127 1994 1217 1232
32. M. Long, S.-H. Huang, C.-H. Wu, G. Shackleford, and A. Jong Lipid raft/caveolae signaling is required for Cryptococcus neoformans invasion into human brain microvascular endothelial cells J. Biomed. Sci. 19 2012 19
33. N.M. Hooper Detergent-insoluble glycosphingolipid/cholesterol-rich membrane domains, lipid rafts and caveolae Mol. Membr. Biol. 16 1999 145 156
34. H. Ponta, L. Sherman, and P.A. Herrlich CD44: from adhesion molecules to signalling regulators Nat. Rev. Mol. Cell Biol. 4 2003 33 45
35. J. Rejman, A. Bragonzi, and M. Conese Role of clathrin- and caveolae-mediated endocytosis in gene transfer mediated by lipo- and polyplexes Mol. Ther. 12 2005 468 474
36. A.W. Wong, S.J. Scales, and D.E. Reilly DNA internalized via caveolae requires microtubule-dependent, Rab7-independent transport to the late endocytic pathway for delivery to the nucleus J. Biol. Chem. 282 2007 22953 22963